Research map: Patient cell drug profiling identifies p53-linked vulnerabilities in refractory lymphoid malignancies

Back to the article

Papers in this map

  1. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays · Ji-Hu Zhang · 1999 · 7028 citations · Cited by this paper
  2. Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers · 2026 · Related
  3. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms · Rita Alaggio · 2022 · 4022 citations · Cited by this paper
  4. Anaplastic thyroid cancer: review of precision therapy options and advances · 2026 · Related
  5. Treatment of Acute Lymphoblastic Leukemia · Ching‐Hon Pui · 2006 · 2000 citations · Cited by this paper
  6. Integrated prediction of lung cancer histology and molecular profiles from small bronchoscopic tumor specimens · 2026 · Related
  7. Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma · Matthew Steven Davids · 2017 · 765 citations · Cited by this paper
  8. Comprehensive multi-omic dissection and AI-prioritized target identification in inverted papilloma–associated sinonasal squamous cell carcinoma · 2026 · Related
  9. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry · Fredrik Ellin · 2014 · 401 citations · Cited by this paper
  10. snRNA-seq of acral melanoma reveals heterogeneity and identifies novel progression marker and cancer-associated fibroblasts subpopulation · 2026 · Related
  11. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies · Bhagwan Yadav · 2014 · 382 citations · Cited by this paper
  12. Prediction of single cell expression from low-plex immunofluorescence images for guiding precision oncology · 2026 · Related
  13. Functional precision cancer medicine—moving beyond pure genomics · Anthony G. Letai · 2017 · 380 citations · Cited by this paper
  14. Single-cell ploidy analysis reveals polyploidy effects on tumor aggressiveness and immune suppression in intrahepatic cholangiocarcinoma · 2026 · Related
  15. Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders · Christoph Kornauth · 2021 · 215 citations · Cited by this paper
  16. Discordance in molecular classification of primary and metastatic endometrial cancer: implications for precision treatment · 2026 · Related
  17. Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia · Disha Malani · 2021 · 209 citations · Cited by this paper
  18. Deep learning-based segmentation and subtype prediction of renal cell carcinoma on contrast-enhanced CT · 2026 · Related
  19. Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis · Roberta Di Blasi · 2022 · 165 citations · Cited by this paper
  20. Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening · Gabriele Picco · 2019 · 139 citations · Cited by this paper
  21. Treatment resistance in diffuse large B-cell lymphoma · Michael Y. He · 2021 · 138 citations · Cited by this paper
  22. Breeze: an integrated quality control and data analysis application for high-throughput drug screening · Swapnil Potdar · 2020 · 114 citations · Cited by this paper
  23. Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma · Christopher Joseph Melani · 2024 · 75 citations · Cited by this paper
  24. Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Toby Andrew Eyre · 2025 · 72 citations · Cited by this paper
  25. p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes · Lilian Amrein · 2010 · 52 citations · Cited by this paper
  26. Exposure time versus cytotoxicity for anticancer agents · David M. Evans · 2019 · 39 citations · Cited by this paper
  27. Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy · Russell B. Foxall · 2021 · 39 citations · Cited by this paper
  28. Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020 · Minna Harmanen · 2022 · 24 citations · Cited by this paper
  29. Standardized assays to monitor drug sensitivity in hematologic cancers · Pilar Ayuda Durán · 2023 · 22 citations · Cited by this paper
  30. Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database · Peter Borchmann · 2023 · 18 citations · Cited by this paper
  31. Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro · Lilian Amrein · 2009 · 12 citations · Cited by this paper
  32. The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome · Kristina Noring · 2021 · 12 citations · Cited by this paper
  33. Delineating functional and molecular impact of ex vivo sample handling in precision medicine · Nona Struyf · 2024 · 11 citations · Cited by this paper
  34. Venetoclax-Based Regimen in Refractory or Relapsed Pediatric Acute Lymphoblastic Leukemia · Lin Zhang · 2025 · 3 citations · Cited by this paper
  35. Low Hodgkin/Reed-Sternberg Cell Density Assessed with Automated Image Analysis Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients · Vít Procházka · 2015 · 1 citation · Cited by this paper
  36. Untitled · Cited by this paper
  37. Untitled · Cited by this paper

Source: OpenAlex (CC0)